More aggressive breast cancers tend to be of basal‐like and human epidermal growth factor receptor 2 (HER2)‐enriched intrinsic molecular subtypes,6 hormone‐receptor (ER) negative,7 higher grade and proliferation status, larger tumor size and lymph node‐positive involvement.8, 9. Here, ERBB2 is linked to neoplasm.